Home › Biotech Weekly: Reviewing The
 

Keywords :   


Biotech Weekly: Reviewing The

2015-09-01 17:58:35| Biotech - Topix.net

The recent huge gains seen by holders of Aquinox Pharmaceuticals , Celsus Therapeutics , and Recro Pharma illustrate the potential of the Of the 35 names on the screen, I highlight Roka Biosciences, Nexvet Biopharma, OXiGENE, MEI Pharma, Biota Pharmaceuticals, Celladon, and Venaxis as names I like. I highlight Affymax, Tikro Technologies, Cadus Corporation, and Natural Alternatives International as potential investment opportunities, but cases where I need to do more due diligence.

Tags: weekly reviewing biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »